Dr. Ameer Malik Elbuluk, MD

Dr. Elbuluk practices at Kaiser Foundation Health Plan of the Northwest in Portland, Oregon.

Dr. Elbuluk's NPI, 1689178808, was assigned on March 21, 2018. Dr. Elbuluk graduated from David Geffen School of Medicine at UCLA in 2018. Dr. Elbuluk's California license number on file is A185241.

Dr. Elbuluk's primary practice is Kaiser Foundation Health Plan of the Northwest, at 500 NE Multnomah St, Portland, OR 97232 in Multnomah County. The practice phone is (503) 813-2440.

Dr. Elbuluk's primary practice is Kaiser Foundation Health Plan of the Northwest in Portland, Oregon. Dr. Elbuluk is also affiliated with Hillcrest Medical Center. The medical group on file is Kaiser Permanente Northwest. Dmand AI also links Dr. Elbuluk to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elbuluk practices. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Elbuluk's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Dr. Elbuluk's licenses on file in 4 states: California, Oregon, Washington and New York.

Dmand AI lists arthritis among the conditions Dr. Elbuluk treats.

CMS data shows 97 Medicare services from Dr. Elbuluk across 2 procedure codes in 2024, for 112 Medicare patients. Medicare paid $15,586 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 112 Medicare patients who saw Dr. Elbuluk in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have arthritis, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Elbuluk's median patient age at 65, with 61% women.

In 2024, Dr. Elbuluk wrote 20 Medicare Part D claims for 19 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $94 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Elbuluk for performance year 2024, reported as part of a group. Dr. Elbuluk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Elbuluk, published from 2017 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Arthroplasty, Replacement, Hip, Postoperative Complications and Acetabulum. Dr. Elbuluk has published most often in J Arthroplasty. Dr. Elbuluk's most frequent co-authors are Jonathan Matthew Vigdorchik, MD, Ran Schwarzkopf, MD, MSc and Seth Allen Jerabek, MD.

CMS Open Payments shows 18 general payments to Dr. Elbuluk from 6 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 82% of the total. Medical Device Business Services, Inc. paid the most, $481.

Dr. Elbuluk graduated from David Geffen School of Medicine at UCLA in 2018.

Dr. Elbuluk is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.